1
|
Wynn TA and Ramalingam TR: Mechanisms of
fibrosis: Therapeutic translation for fibrotic disease. Nat Med.
18:1028–1040. 2012. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Crabos M, Roth M, Hahn AW and Erne P:
Characterization of angiotensin II receptors in cultured adult rat
cardiac fibroblasts. Coupling to signaling systems and gene
expression. J Clin Invest. 93:2372–2378. 1994. View Article : Google Scholar : PubMed/NCBI
|
3
|
Dostal DE, Booz GW and Baker KM:
Angiotensin II signalling pathways in cardiac fibroblasts:
Conventional versus novel mechanisms in mediating cardiac growth
and function. Mol Cell Biochem. 157:15–21. 1996. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sadoshima J and Izumo S: Molecular
characterization of angiotensin II-induced hypertrophy of cardiac
myocytes and hyperplasia of cardiac fibroblasts. Critical role of
the AT1 receptor subtype. Circ Res. 73:413–423. 1993. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhou G, Kandala JC, Tyagi SC, Katwa LC and
Weber KT: Effects of angiotensin II and aldosterone on collagen
gene expression and protein turnover in cardiac fibroblasts. Mol
Cell Biochem. 154:171–178. 1996. View Article : Google Scholar : PubMed/NCBI
|
6
|
Schorb W, Booz GW, Dostal DE, Conrad KM,
Chang KC and Baker KM: Angiotensin II is mitogenic in neonatal rat
cardiac fibroblasts. Circ Res. 72:1245–1254. 1993. View Article : Google Scholar : PubMed/NCBI
|
7
|
Jia Y, Xu J, Yu Y, Guo J, Liu P, Chen S
and Jiang J: Nifedipine inhibits angiotensin II-induced cardiac
fibrosis via downregulating Nox4-derived ROS generation and
suppressing ERK1/2, JNK signaling pathways. Pharmazie. 68:435–441.
2013.PubMed/NCBI
|
8
|
Sassoli C, Chellini F, Pini A, Tani A,
Nistri S, Nosi D, Zecchi-Orlandini S, Bani D and Formigli L:
Relaxin prevents cardiac fibroblast-myofibroblast transition via
notch-1-mediated inhibition of TGF-beta/Smad3 signaling. PLoS One.
8:e638962013. View Article : Google Scholar
|
9
|
Foo RS, Siow RC, Brown MJ and Bennett MR:
Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat
cardiac myocyte apoptosis but not hypertrophy. J Cell Physiol.
209:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kajstura J, Cigola E, Malhotra A, Li P,
Cheng W, Meggs LG and Anversa P: Angiotensin II induces apoptosis
of adult ventricular myocytes in vitro. J Mol Cell Cardiol.
29:859–870. 1997. View Article : Google Scholar : PubMed/NCBI
|
11
|
Choudhary R, Baker KM and Pan J: All-trans
retinoic acid prevents angiotensin II- and mechanical
stretch-induced reactive oxygen species generation and
cardiomyocyte apoptosis. J Cell Physiol. 215:172–181. 2008.
View Article : Google Scholar
|
12
|
Graiani G, Lagrasta C, Migliaccio E,
Spillmann F, Meloni M, Madeddu P, Quaini F, Padura IM, Lanfrancone
L, Pelicci P and Emanueli C: Genetic deletion of the p66Shc adaptor
protein protects from angiotensin II-induced myocardial damage.
Hypertension. 46:433–440. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pan W, Zhong Y, Cheng C, Liu B, Wang L, Li
A, Xiong L and Liu S: MiR-30-regulated autophagy mediates
angiotensin II-induced myocardial hypertrophy. PLoS One.
8:e539502013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Yang C, Liu Z, Liu K and Yang P:
Mechanisms of Ghrelin anti-heart failure: Inhibition of Ang
II-induced cardiomyocyte apoptosis by down-regulating AT1R
expression. PLoS One. 9:e857852014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu K, Deng X, Gong L, Chen X, Wang S,
Chen H, Chen X, Amrit B and He S: The effect of intermedin on
angiotensin II and endothelin-1 induced ventricular myocyte
hypertrophy in neonatal rat. Clin Lab. 59:589–596. 2013.PubMed/NCBI
|
16
|
Rosenkranz S: TGF-beta1 and angiotensin
networking in cardiac remodeling. Cardiovasc Res. 63:423–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhu MJ, Wang YP, Xie SY, Liu WH, Li B,
Wang YX, Wang H and Zhang BL: Protective effects of Jiashen
Prescription () on myocardial infarction in rats. Chin J Integr
Med. 21:417–422. 2015. View Article : Google Scholar
|
18
|
Yin D, Liu Z, Peng D, Yang Y, Gao X, Xu F
and Han L: Serum containing Tao-Hong-Si-Wu decoction induces human
endothelial cell VEGF production via PI3K/Akt-eNOS signaling. Evid
Based Complement Alternat Med. 2013:1951582013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hong HJ, Liu JC, Cheng TH and Chan P:
Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt
pathway in neonatal rat cardiomyocytes. Acta Pharmacol Sin.
31:1569–1575. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Chen R, Xue J and Xie M: Osthole regulates
TGF-β1 and MMP-2/9 expressions via activation of PPARα/γ in
cultured mouse cardiac fibroblasts stimulated with angiotensin II.
J Pharm Pharm Sci. 16:732–741. 2013. View
Article : Google Scholar
|
21
|
Zou Y, Lin L, Ye Y, Wei J, Zhou N, Liang
Y, Gong H, Li L, Wu J, Li Y, et al: Qiliqiangxin inhibits the
development of cardiac hypertrophy, remodeling, and dysfunction
during 4 weeks of pressure overload in mice. J Cardiovasc
Pharmacol. 59:268–280. 2012. View Article : Google Scholar
|
22
|
Zhou J, Jiang K, Ding X, Fu M, Wang S, Zhu
L, He T, Wang J, Sun A, Hu K, et al: Qiliqiangxin inhibits
angiotensin II-induced transdifferentiation of rat cardiac
fibroblasts through suppressing interleukin-6. J Cell Mol Med.
19:1114–1121. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Guo ZJ, Gao XM, Wang BH, Xu Q, Wang Y and
Liu YP: Jiashenfang's effect to the nerve-internal secretion of CHF
rats. J Liaoning Univ Tradit Chin Med (Chin). 11:196–197. 2009.
|
24
|
Schröder D, Heger J, Piper HM and Euler G:
Angiotensin II stimulates apoptosis via TGF-beta1 signaling in
ventricular cardiomyocytes of rat. J Mol Med (Berl). 84:975–983.
2006. View Article : Google Scholar
|
25
|
Tao X, Fan J, Kao G, Zhang X, Su L, Yin Y
and Zrenner B: Angiotensin-(1–7) attenuates angiotensin II-induced
signalling associated with activation of a tyrosine phosphatase in
Sprague-Dawley rats cardiac fibroblasts. Biol Cell. 106:182–192.
2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Cheng TH, Shih NL, Chen SY, Wang DL and
Chen JJ: Reactive oxygen species modulate endothelin-I-induced
c-fos gene expression in cardiomyocytes. Cardiovasc Res.
41:654–662. 1999. View Article : Google Scholar : PubMed/NCBI
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
28
|
Zhang H, Wu J, Dong H, Khan SA, Chu ML and
Tsuda T: Fibulin-2 deficiency attenuates angiotensin II-induced
cardiac hypertrophy by reducing transforming growth factor-β
signalling. Clin Sci (Lond). 126:275–288. 2014. View Article : Google Scholar
|
29
|
Dai B, Cui M, Zhu M, Su WL, Qiu MC and
Zhang H: STAT1/3 and ERK1/2 synergistically regulate cardiac
fibrosis induced by high glucose. Cell Physiol Biochem. 32:960–971.
2013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Cao Y, Xu W and Xiong S: Adoptive transfer
of regulatory T cells protects against Coxsackievirus B3-induced
cardiac fibrosis. PLoS One. 8:e749552013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Kazakov A, Hall R, Jagoda P, Bachelier K,
Müller-Best P, Semenov A, Lammert F, Böhm M and Laufs U: Inhibition
of endothelial nitric oxide synthase induces and enhances
myocardial fibrosis. Cardiovasc Res. 100:211–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Souders CA, Bowers SL and Baudino TA:
Cardiac fibroblast: The renaissance cell. Circ Res. 105:1164–1176.
2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Li P, Wang D, Lucas J, Oparil S, Xing D,
Cao X, Novak L, Renfrow MB and Chen YF: Atrial natriuretic peptide
inhibits transforming growth factor beta-induced Smad signaling and
myofibroblast transformation in mouse cardiac fibroblasts. Circ
Res. 102:185–192. 2008. View Article : Google Scholar
|